- Home
- PAX vs HRMY Comparison
PAX vs HRMY Comparison
Compare PAX & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAX
- HRMY
- Stock Information
- Founded
- PAX 1988
- HRMY 2017
- Country
- PAX Cayman Islands
- HRMY United States
- Employees
- PAX N/A
- HRMY N/A
- Industry
- PAX Investment Managers
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- PAX Finance
- HRMY Health Care
- Exchange
- PAX Nasdaq
- HRMY Nasdaq
- Market Cap
- PAX 2.2B
- HRMY 1.8B
- IPO Year
- PAX 2021
- HRMY 2020
- Fundamental
- Price
- PAX $13.67
- HRMY $37.22
- Analyst Decision
- PAX Strong Buy
- HRMY Strong Buy
- Analyst Count
- PAX 1
- HRMY 9
- Target Price
- PAX $14.00
- HRMY $55.33
- AVG Volume (30 Days)
- PAX 484.8K
- HRMY 598.7K
- Earning Date
- PAX 08-01-2025
- HRMY 08-05-2025
- Dividend Yield
- PAX 6.39%
- HRMY N/A
- EPS Growth
- PAX N/A
- HRMY 13.13
- EPS
- PAX 0.45
- HRMY 2.62
- Revenue
- PAX $389,900,000.00
- HRMY $744,852,000.00
- Revenue This Year
- PAX $5.53
- HRMY $20.33
- Revenue Next Year
- PAX N/A
- HRMY $17.67
- P/E Ratio
- PAX $30.18
- HRMY $14.06
- Revenue Growth
- PAX 22.70
- HRMY 20.62
- 52 Week Low
- PAX $9.43
- HRMY $26.47
- 52 Week High
- PAX $14.52
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- PAX 50.79
- HRMY 70.43
- Support Level
- PAX $13.38
- HRMY $35.04
- Resistance Level
- PAX $14.44
- HRMY $37.21
- Average True Range (ATR)
- PAX 0.30
- HRMY 1.09
- MACD
- PAX -0.09
- HRMY 0.40
- Stochastic Oscillator
- PAX 30.89
- HRMY 99.07
About PAX Patria Investments Limited
Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.